{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:15:31Z","timestamp":1792815331369,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000381"],"award-info":[{"award-number":["82000381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770255"],"award-info":[{"award-number":["81770255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010009","name":"Heilongjiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["LBH\u2011Z19188"],"award-info":[{"award-number":["LBH\u2011Z19188"]}],"id":[{"id":"10.13039\/501100010009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Project of Key Laboratory of Myocardial Ischemia, Ministry of Education","award":["KF202103"],"award-info":[{"award-number":["KF202103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heart failure (HF) after myocardial infarction (MI) is a prevalent disease with a poor prognosis. Relieving pathological cardiac remodeling and preserving cardiac function is a critical link in the treatment of post-MI HF. Thus, more new therapeutic targets are urgently needed. The expression of ADAM17 is increased in patients with acute MI, but its functional role in post-MI HF remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To address this question, we examined the effects of ADAM17 on the severity and prognosis of HF within 1 year of MI in 152 MI patients with or without HF. In mechanistic studies, the effects of ADAM17 on ventricular remodeling and systolic function were extensively assessed at the tissue and cellular levels by establishing animal model of post-MI HF and in vitro hypoxic cell model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>High levels of ADAM17 predicted a higher incidence of post-MI HF, poorer cardiac function and higher mortality. Animal studies demonstrated that ADAM17 promoted the occurrence of post-MI HF, as indicated by increased infarct size, cardiomyocyte hypertrophy, myocardial interstitial collagen deposition and cardiac failure. ADAM17 knock down significantly improved pathological cardiac remodeling and cardiac function in mice with MI. Mechanistically, activated ADAM17 inhibited the cardioprotective effects of ACE2 by promoting hydrolytic shedding of the transmembrane protein ACE2 in cardiomyocytes, which subsequently mediated the occurrence of cardiac remodeling and the progression of heart failure. Moreover, the activation of ADAM17 in hypoxic cardiomyocytes was dependent on p38 MAPK phosphorylation at threonine 735.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These data highlight a novel and important mechanism for ADAM17 to cause post-MI HF, which will hopefully be a new potential target for early prediction or intervention of post-MI HF.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12964-023-01087-3","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:03:03Z","timestamp":1681297383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["P38 MAPK activated ADAM17 mediates ACE2 shedding and promotes cardiac remodeling and heart failure after myocardial infarction"],"prefix":"10.1186","volume":"21","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bike","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"issue":"3","key":"1087_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","volume":"6","author":"MC Bahit","year":"2018","unstructured":"Bahit MC, Kochar A, Granger CB. Post-myocardial infarction heart failure. JACC Heart Fail. 2018;6(3):179\u201386.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1087_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","volume":"4","author":"MA Konstam","year":"2011","unstructured":"Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011;4(1):98\u2013108.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"1087_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","volume":"35","author":"JN Cohn","year":"2000","unstructured":"Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling\u2013concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol. 2000;35(3):569\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1087_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, Anker SD, Atherton J, Bohm M, Butler J, et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the european society of cardiology, japanese heart failure society and writing committee of the universal definition of heart failure. J Card Fail. 2021;27(4):387\u2013413.","journal-title":"J Card Fail"},{"issue":"1","key":"1087_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1124\/pharmrev.120.000082","volume":"73","author":"A Patwardhan","year":"2021","unstructured":"Patwardhan A, Cheng N, Trejo J. Post-translational modifications of g protein-coupled receptors control cellular signaling dynamics in space and time. Pharmacol Rev. 2021;73(1):120\u201351.","journal-title":"Pharmacol Rev"},{"key":"1087_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.yjmcc.2021.01.012","volume":"154","author":"J Zhu","year":"2021","unstructured":"Zhu J, Steinberg SF. beta1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte beta1-adrenergic receptors. J Mol Cell Cardiol. 2021;154:70\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"1087_CR7","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med. 2022;86:101097.","journal-title":"Mol Aspects Med"},{"issue":"6","key":"1087_CR8","doi-asserted-by":"publisher","first-page":"152410","DOI":"10.1016\/j.prp.2019.04.002","volume":"215","author":"S Dusterhoft","year":"2019","unstructured":"Dusterhoft S, Lokau J, Garbers C. The metalloprotease ADAM17 in inflammation and cancer. Pathol Res Pract. 2019;215(6):152410.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"1087_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00018-019-03184-4","volume":"77","author":"F Scharfenberg","year":"2020","unstructured":"Scharfenberg F, Helbig A, Sammel M, Benzel J, Schlomann U, Peters F, Wichert R, Bettendorff M, Schmidt-Arras D, Rose-John S, et al. Degradome of soluble ADAM10 and ADAM17 metalloproteases. Cell Mol Life Sci. 2020;77(2):331\u201350.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"1087_CR10","doi-asserted-by":"publisher","first-page":"eabm2882","DOI":"10.1126\/sciadv.abm2882","volume":"8","author":"XY Ho","year":"2022","unstructured":"Ho XY, Coakley S, Amor R, Anggono V, Hilliard MA. The metalloprotease ADM-4\/ADAM17 promotes axonal repair. Sci Adv. 2022;8(11):eabm2882.","journal-title":"Sci Adv"},{"key":"1087_CR11","doi-asserted-by":"publisher","first-page":"732952","DOI":"10.3389\/fcell.2021.732952","volume":"9","author":"J Adu-Amankwaah","year":"2021","unstructured":"Adu-Amankwaah J, Adzika GK, Adekunle AO, Ndzie Noah ML, Mprah R, Bushi A, Akhter N, Huang F, Xu Y, Adzraku SY, et al. ADAM17, a key player of cardiac inflammation and fibrosis in heart failure development during chronic catecholamine stress. Front Cell Dev Biol. 2021;9:732952.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1087_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41590-021-01093-y","volume":"23","author":"S Kubo","year":"2022","unstructured":"Kubo S, Fritz JM, Raquer-McKay HM, Kataria R, Vujkovic-Cvijin I, Al-Shaibi A, Yao Y, Zheng L, Zou J, Waldman AD, et al. Congenital iRHOM2 deficiency causes ADAM17 dysfunction and environmentally directed immunodysregulatory disease. Nat Immunol. 2022;23(1):75\u201385.","journal-title":"Nat Immunol"},{"issue":"9","key":"1087_CR13","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s00018-021-03779-w","volume":"78","author":"T Kawai","year":"2021","unstructured":"Kawai T, Elliott KJ, Scalia R, Eguchi S. Contribution of ADAM17 and related ADAMs in cardiovascular diseases. Cell Mol Life Sci. 2021;78(9):4161\u201387.","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"1087_CR14","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1038\/s41388-022-02309-7","volume":"41","author":"YT Tsai","year":"2022","unstructured":"Tsai YT, Li CY, Huang YH, Chang TS, Lin CY, Chuang CH, Wang CY, Anuraga G, Chang TH, Shih TC, et al. Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts. Oncogene. 2022;41(21):3011\u201323.","journal-title":"Oncogene"},{"issue":"1","key":"1087_CR15","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1038\/s41598-022-08227-8","volume":"12","author":"W Xiao","year":"2022","unstructured":"Xiao W, Pinilla-Baquero A, Faulkner J, Song X, Prabhakar P, Qiu H, Moremen KW, Ludwig A, Dempsey PJ, Azadi P, et al. Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis. Sci Rep. 2022;12(1):4352.","journal-title":"Sci Rep"},{"issue":"11","key":"1087_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3390\/cancers11111736","volume":"11","author":"N Schumacher","year":"2019","unstructured":"Schumacher N, Rose-John S. ADAM17 activity and IL-6 trans-signaling in inflammation and cancer. Cancers. 2019;11(11):1736.","journal-title":"Cancers"},{"issue":"10","key":"1087_CR17","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1002\/1521-4141(2002010)32:10<2965::AID-IMMU2965>3.0.CO;2-V","volume":"32","author":"V Marin","year":"2002","unstructured":"Marin V, Montero-Julian F, Gres S, Bongrand P, Farnarier C, Kaplanski G. Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type. Eur J Immunol. 2002;32(10):2965\u201370.","journal-title":"Eur J Immunol"},{"key":"1087_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3389\/fphar.2020.01154","volume":"11","author":"TM de Queiroz","year":"2020","unstructured":"de Queiroz TM, Lakkappa N, Lazartigues E. ADAM17-mediated shedding of inflammatory cytokines in hypertension. Front Pharmacol. 2020;11:1154.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1087_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ejheart.2004.02.007","volume":"6","author":"M Satoh","year":"2004","unstructured":"Satoh M, Iwasaka J, Nakamura M, Akatsu T, Shimoda Y, Hiramori K. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Eur J Heart Fail. 2004;6(7):869\u201375.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1087_CR20","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCHEARTFAILURE.114.002029","volume":"8","author":"D Fan","year":"2015","unstructured":"Fan D, Takawale A, Shen M, Wang W, Wang X, Basu R, Oudit GY, Kassiri Z. Cardiomyocyte a disintegrin and metalloproteinase 17 (ADAM17) is essential in post-myocardial infarction repair by regulating angiogenesis. Circ Heart Fail. 2015;8(5):970\u20139.","journal-title":"Circ Heart Fail"},{"issue":"19","key":"1087_CR21","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","volume":"41","author":"IE Sama","year":"2020","unstructured":"Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, Rienstra M, Friedrich AW, Samani NJ, Ng LL, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41(19):1810\u20137.","journal-title":"Eur Heart J"},{"issue":"10","key":"1087_CR22","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126(10):1456\u201374.","journal-title":"Circ Res"},{"issue":"5","key":"1087_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.119.13133","volume":"74","author":"S Mukerjee","year":"2019","unstructured":"Mukerjee S, Gao H, Xu J, Sato R, Zsombok A, Lazartigues E. ACE2 and ADAM17 interaction regulates the activity of presympathetic neurons. Hypertension. 2019;74(5):1181\u201391.","journal-title":"Hypertension"},{"issue":"8","key":"1087_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB, Zhong JC, Grant MB, Oudit GY. Role of the ACE2\/angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure. Circ Res. 2016;118(8):1313\u201326.","journal-title":"Circ Res"},{"key":"1087_CR25","doi-asserted-by":"crossref","unstructured":"Schweitzer KS, Crue T, Nall JM, Foster D, Sajuthi S, Correll KA, Nakamura M, Everman JL, Downey GP, Seibold MA et al: Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells. Eur Respir J 2021;58(1).","DOI":"10.1183\/13993003.03988-2020"},{"issue":"4","key":"1087_CR26","doi-asserted-by":"publisher","first-page":"e9976","DOI":"10.15252\/emmm.201809976","volume":"11","author":"MI Saad","year":"2019","unstructured":"Saad MI, Alhayyani S, McLeod L, Yu L, Alanazi M, Deswaerte V, Tang K, Jarde T, Smith JA, Prodanovic Z, et al. ADAM17 selectively activates the IL-6 trans-signaling\/ERK MAPK axis in KRAS-addicted lung cancer. EMBO Mol Med. 2019;11(4):e9976.","journal-title":"EMBO Mol Med"},{"issue":"11","key":"1087_CR27","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.3390\/ijms22115520","volume":"22","author":"V Palau","year":"2021","unstructured":"Palau V, Nugraha B, Benito D, Pascual J, Emmert MY, Hoerstrup SP, Riera M, Soler MJ. Both specific endothelial and proximal tubular Adam17 deletion protect against diabetic nephropathy. Int J Mol Sci. 2021;22(11):5520.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1087_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/HYPERTENSIONAHA.119.14556","volume":"76","author":"DN Meijles","year":"2020","unstructured":"Meijles DN, Cull JJ, Markou T, Cooper STE, Haines ZHR, Fuller SJ, O\u2019Gara P, Sheppard MN, Harding SE, Sugden PH, et al. Redox regulation of cardiac ASK1 (apoptosis signal-regulating kinase 1) controls p38-MAPK (mitogen-activated protein kinase) and orchestrates cardiac remodeling to hypertension. Hypertension. 2020;76(4):1208\u201318.","journal-title":"Hypertension"},{"issue":"9","key":"1087_CR29","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1096\/fj.201701455RR","volume":"32","author":"SA Bageghni","year":"2018","unstructured":"Bageghni SA, Hemmings KE, Zava N, Denton CP, Porter KE, Ainscough JFX, Drinkhill MJ, Turner NA. Cardiac fibroblast-specific p38alpha MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism. FASEB J. 2018;32(9):4941\u201354.","journal-title":"FASEB J"},{"issue":"18","key":"1087_CR30","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Executive group on behalf of the joint european society of cardiology\/American college of cardiology\/American heart association\/World heart federation task force for the universal definition of myocardial I: Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1087_CR31","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","volume":"126","author":"S Ye","year":"2020","unstructured":"Ye S, Luo W, Khan ZA, Wu G, Xuan L, Shan P, Lin K, Chen T, Wang J, Hu X, et al. Celastrol Attenuates angiotensin II-induced cardiac remodeling by targeting STAT3. Circ Res. 2020;126(8):1007\u201323.","journal-title":"Circ Res"},{"issue":"12","key":"1087_CR32","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1093\/nar\/gkx438","volume":"45","author":"P Perez-Arnaiz","year":"2017","unstructured":"Perez-Arnaiz P, Bruck I, Colbert MK, Kaplan DL. An intact Mcm10 coiled-coil interaction surface is important for origin melting, helicase assembly and the recruitment of Pol-alpha to Mcm2-7. Nucleic Acids Res. 2017;45(12):7261\u201375.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1087_CR33","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/ijms23031368","volume":"23","author":"M Bienstein","year":"2022","unstructured":"Bienstein M, Minond D, Schwaneberg U, Davari MD, Yildiz D. In silico and experimental ADAM17 kinetic modeling as basis for future screening system for modulators. Int J Mol Sci. 2022;23(3):1368.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1087_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.lfs.2013.12.028","volume":"97","author":"H Oikawa","year":"2014","unstructured":"Oikawa H, Maesawa C, Tatemichi Y, Nishinari Y, Nishiya M, Mizugai H, Ikeda A, Oikawa K, Takikawa Y, Masuda T. A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells. Life Sci. 2014;97(2):137\u201344.","journal-title":"Life Sci"},{"issue":"2","key":"1087_CR35","doi-asserted-by":"publisher","first-page":"151887","DOI":"10.1016\/j.imbio.2019.11.022","volume":"225","author":"S Sultana","year":"2020","unstructured":"Sultana S, Bishayi B. Potential anti-arthritic and anti-inflammatory effects of TNF-alpha processing inhibitor-1 (TAPI-1): a new approach to the treatment of S. aureus arthritis. Immunobiology. 2020;225(2):151887.","journal-title":"Immunobiology"},{"issue":"1","key":"1087_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0625.2009.00973.x","volume":"19","author":"M Terao","year":"2010","unstructured":"Terao M, Murota H, Kitaba S, Katayama I. Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma. Exp Dermatol. 2010;19(1):38\u201343.","journal-title":"Exp Dermatol"},{"issue":"23","key":"1087_CR37","doi-asserted-by":"publisher","first-page":"23609","DOI":"10.18632\/aging.103563","volume":"12","author":"L Gou","year":"2020","unstructured":"Gou L, Xue C, Tang X, Fang Z. Inhibition of Exo-miR-19a-3p derived from cardiomyocytes promotes angiogenesis and improves heart function in mice with myocardial infarction via targeting HIF-1alpha. Aging (Albany NY). 2020;12(23):23609\u201318.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"1087_CR38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41419-019-1760-5","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhu L, Feng P, Tan Y, Zhang B, Gao E, Wang X, Fan C, Wang X, Yi W, et al. C1q\/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction. Cell Death Dis. 2019;10(7):530.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1087_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41467-017-02280-y","volume":"9","author":"CY Liu","year":"2018","unstructured":"Liu CY, Zhang YH, Li RB, Zhou LY, An T, Zhang RC, Zhai M, Huang Y, Yan KW, Dong YH, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun. 2018;9(1):29.","journal-title":"Nat Commun"},{"key":"1087_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1478-811X-12-6","volume":"12","author":"MI Ashraf","year":"2014","unstructured":"Ashraf MI, Ebner M, Wallner C, Haller M, Khalid S, Schwelberger H, Koziel K, Enthammer M, Hermann M, Sickinger S, et al. A p38MAPK\/MK2 signaling pathway leading to redox stress, cell death and ischemia\/reperfusion injury. Cell Commun Signal. 2014;12:6.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"1087_CR41","doi-asserted-by":"publisher","first-page":"e017791","DOI":"10.1161\/JAHA.120.017791","volume":"10","author":"M Ruiz","year":"2021","unstructured":"Ruiz M, Khairallah M, Dingar D, Vaniotis G, Khairallah RJ, Lauzier B, Thibault S, Trepanier J, Shi Y, Douillette A, et al. MK2-deficient mice are bradycardic and display delayed hypertrophic remodeling in response to a chronic increase in afterload. J Am Heart Assoc. 2021;10(4):e017791.","journal-title":"J Am Heart Assoc"},{"issue":"5 Pt B","key":"1087_CR42","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.bbadis.2017.07.015","volume":"1864","author":"M Ruiz","year":"2018","unstructured":"Ruiz M, Coderre L, Allen BG, Des Rosiers C. Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5 Pt B):1914\u201322.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11\u201312","key":"1087_CR43","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10495-020-01639-9","volume":"25","author":"Y Li","year":"2020","unstructured":"Li Y, Qi Q, Yang WC, Zhang TL, Lu CC, Yao YJ, Kong WH, Zhao J. Sphingosylphosphorylcholine alleviates hypoxia-caused apoptosis in cardiac myofibroblasts via CaM\/p38\/STAT3 pathway. Apoptosis. 2020;25(11\u201312):853\u201363.","journal-title":"Apoptosis"},{"key":"1087_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32662","author":"X Liu","year":"2022","unstructured":"Liu X, Tan S, Liu H, Jiang J, Wang X, Li L, Wu B. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology. 2022. https:\/\/doi.org\/10.1002\/hep.32662.","journal-title":"Hepatology"},{"issue":"1","key":"1087_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91\u2013112.","journal-title":"Circ Res"},{"issue":"1","key":"1087_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41392-022-01054-3","volume":"7","author":"F Xue","year":"2022","unstructured":"Xue F, Cheng J, Liu Y, Cheng C, Zhang M, Sui W, Chen W, Hao P, Zhang Y, Zhang C. Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. Signal Transduct Target Ther. 2022;7(1):259.","journal-title":"Signal Transduct Target Ther"},{"key":"1087_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.lfs.2016.02.097","volume":"151","author":"DY Zheng","year":"2016","unstructured":"Zheng DY, Zhao J, Yang JM, Wang M, Zhang XT. Enhanced ADAM17 expression is associated with cardiac remodeling in rats with acute myocardial infarction. Life Sci. 2016;151:61\u20139.","journal-title":"Life Sci"},{"issue":"4","key":"1087_CR48","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/HYPERTENSIONAHA.116.07566","volume":"68","author":"D Fan","year":"2016","unstructured":"Fan D, Takawale A, Shen M, Samokhvalov V, Basu R, Patel V, Wang X, Fernandez-Patron C, Seubert JM, Oudit GY, et al. A Disintegrin and metalloprotease-17 regulates pressure overload-induced myocardial hypertrophy and dysfunction through proteolytic processing of integrin beta1. Hypertension. 2016;68(4):937\u201348.","journal-title":"Hypertension"},{"issue":"12","key":"1087_CR49","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/CIRCRESAHA.112.279109","volume":"111","author":"JL Lucitti","year":"2012","unstructured":"Lucitti JL, Mackey JK, Morrison JC, Haigh JJ, Adams RH, Faber JE. Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and a disintegrin and metalloprotease family members 10 and 17. Circ Res. 2012;111(12):1539\u201350.","journal-title":"Circ Res"},{"issue":"2","key":"1087_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10863-020-09829-5","volume":"52","author":"X Wen","year":"2020","unstructured":"Wen X, Yin Y, Li X, He T, Wang P, Song M, Gao J. Effect of miR-26a-5p targeting ADAM17 gene on apoptosis, inflammatory factors and oxidative stress response of myocardial cells in hypoxic model. J Bioenerg Biomembr. 2020;52(2):83\u201392.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"1087_CR51","doi-asserted-by":"publisher","first-page":"1744980","DOI":"10.1080\/2162402X.2020.1744980","volume":"9","author":"JJ Orme","year":"2020","unstructured":"Orme JJ, Jazieh KA, Xie T, Harrington S, Liu X, Ball M, Madden B, Charlesworth MC, Azam TU, Lucien F, et al. ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance. Oncoimmunology. 2020;9(1):1744980.","journal-title":"Oncoimmunology"},{"key":"1087_CR52","doi-asserted-by":"publisher","first-page":"e5012","DOI":"10.7554\/eLife.35012","volume":"7","author":"U Kunzel","year":"2018","unstructured":"Kunzel U, Grieve AG, Meng Y, Sieber B, Cowley SA, Freeman M. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom\/ADAM17 sheddase complex. Elife. 2018;7:e5012.","journal-title":"Elife"},{"issue":"4","key":"1087_CR53","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.molcel.2010.01.034","volume":"37","author":"P Xu","year":"2010","unstructured":"Xu P, Derynck R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell. 2010;37(4):551\u201366.","journal-title":"Mol Cell"},{"issue":"8","key":"1087_CR54","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/10408363.2021.1942782","volume":"58","author":"A Aimo","year":"2021","unstructured":"Aimo A, Vergaro G, Passino C, Clerico A. Evaluation of pathophysiological relationships between renin-angiotensin and ACE\u2013ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure. Crit Rev Clin Lab Sci. 2021;58(8):530\u201345.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"10256","key":"1087_CR55","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","volume":"396","author":"S Narula","year":"2020","unstructured":"Narula S, Yusuf S, Chong M, Ramasundarahettige C, Rangarajan S, Bangdiwala SI, van Eikels M, Leineweber K, Wu A, Pigeyre M, et al. Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis. Lancet. 2020;396(10256):968\u201376.","journal-title":"Lancet"},{"key":"1087_CR56","doi-asserted-by":"publisher","first-page":"923516","DOI":"10.3389\/fimmu.2022.923516","volume":"13","author":"K Wang","year":"2022","unstructured":"Wang K, Deng H, Song B, He J, Liu S, Fu J, Zhang L, Li D, Balaji KS, Mei Z, et al. The correlation between immune invasion and SARS-COV-2 entry protein ADAM17 in cancer patients by bioinformatic analysis. Front Immunol. 2022;13:923516.","journal-title":"Front Immunol"},{"issue":"20","key":"1087_CR57","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","volume":"141","author":"KJ Clerkin","year":"2020","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648\u201355.","journal-title":"Circulation"},{"issue":"1","key":"1087_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","volume":"27","author":"Q Xiong","year":"2021","unstructured":"Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89\u201395.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"1087_CR59","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265\u201373.","journal-title":"JAMA Cardiol"},{"issue":"8","key":"1087_CR60","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.jcmg.2020.05.017","volume":"13","author":"E Agricola","year":"2020","unstructured":"Agricola E, Beneduce A, Esposito A, Ingallina G, Palumbo D, Palmisano A, Ancona F, Baldetti L, Pagnesi M, Melisurgo G, et al. Heart and lung multimodality imaging in COVID-19. JACC Cardiovasc Imaging. 2020;13(8):1792\u2013808.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"1087_CR61","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.121.18295","volume":"79","author":"K Wang","year":"2022","unstructured":"Wang K, Gheblawi M, Nikhanj A, Munan M, MacIntyre E, O\u2019Neil C, Poglitsch M, Colombo D, Del Nonno F, Kassiri Z, et al. Dysregulation of ACE (angiotensin-converting enzyme)-2 and renin-angiotensin peptides in SARS-CoV-2 mediated mortality and end-organ injuries. Hypertension. 2022;79(2):365\u201378.","journal-title":"Hypertension"},{"issue":"5","key":"1087_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-0368-x","volume":"17","author":"JJ Mourad","year":"2020","unstructured":"Mourad JJ, Levy BI. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. Nat Rev Cardiol. 2020;17(5):313.","journal-title":"Nat Rev Cardiol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01087-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T15:32:19Z","timestamp":1681745539000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01087-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1087"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01087-3","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics of Animal Experiments of the Second Affiliated Hospital of Harbin Medical University and done in accordance with the Declaration of Helsinki (KY2017-249). All mouse experiments were conducted in accordance with the scheme approved by the Ethics of Animal Experiments of the Second Affiliated Hospital of Harbin Medical University (sydwgzr2020-014). Informed consent was obtained from all participants included in this study according to the committee regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}